• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.69% Nasdaq Down0.61%

    Heartware International Inc. (HTWR)

    86.77 Up 0.52(0.60%) 10:32AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    ProfileGet Profile for:
    Heartware International Inc.
    500 Old Connecticut Path
    Framingham, MA 01701
    United States - Map
    Phone: 508-739-0950
    Website: http://www.heartware.com

    Index Membership:N/A
    Industry:Medical Instruments & Supplies
    Full Time Employees:585

    Business Summary 

    HeartWare International, Inc., a medical device company, designs, develops, manufactures, and markets miniaturized implantable heart pumps or ventricular assist devices (VAD) for the treatment of advanced heart failure in the United States, Germany, and internationally. It offers HeartWare Ventricular Assist System, which comprises a VAD or blood pump, patient accessories, and surgical tools designed to provide circulatory support for patients in the advanced stage of heart failure. The company is also developing the MVAD, a miniaturized blood pump intended for chronic heart failure patients; and SYNERGY Circulatory Support System, a partial support system designed to treat less sick, ambulatory, chronic heart failure patients who are not yet inotrope-dependent. The company markets its products directly to clinicians and medical facilities, as well as through medical device distributors. HeartWare International, Inc. is headquartered in Framingham, Massachusetts.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Heartware International Inc.

    Corporate Governance 
    Heartware International Inc.’s ISS Governance QuickScore as of Aug 1, 2015 is 8. The pillar scores are Audit: 1; Board: 2; Shareholder Rights: 7; Compensation: 9.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
    Mr. Douglas E. Godshall M.B.A., 50
    Chief Exec. Officer, Pres, Managing Director and Exec. Director
    Mr. Peter F. McAree , 50
    Chief Financial Officer, Principal Accounting Officer, Sr. VP and Treasurer
    Mr. Mark Strong , 43
    Sr. VP of R&D and Quality Assurance
    Mr. James Schuermann BS, MBA, 47
    Sr. VP of Sales & Marketing
    Dr. Katrin Leadley M.D., 52
    Chief Medical Officer
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders